Publication | Open Access

N-(3-fluoro-4-(2-arylthieno[3,2-b]pyridin-7-yloxy)phenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: A novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitors

Medicinal ChemistryDrug TargetNovel SeriesBiochemistryMedicineNatural SciencesRational Drug DesignPharmacological AgentPharmacotherapyDrug DevelopmentPharmacologyPharmaceutical ChemistryDrug DiscoveryDrug Resistance